Ferronova - Nanoparticle Trial Begins in Patients With Gastric and Oesophageal Cancers
ADELAIDE, Australia--(BUSINESS WIRE)--Apr 9, 2024--
Source: eagletribune.com
Biomedtech Horizons Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biomedtech Horizons Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biomedtech Horizons Program Today - Breaking & Trending Today
Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
ADELAIDE, Australia--(BUSINESS WIRE)--Australian biotech company Ferronova announced today that it has signed a licensing agreement with the Purdue Research Foundation (PRF) for the application of
Source: ibtimes.com.au
Assessment of a non-invasive brain pulse monitor
Intracranial pressure monitoring requires placing a hole in the skull through which an invasive pressure monitor is inserted into the brain
Source: dovepress.com
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal and brain tumors. Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a further A$3 million secured via an Australian Government Co-operative Research Centers Project (CRC-P)grant.* Existing Ferronova shareholders, led by Uniseed with Artesian Venture Partne...
Source: philippinetimes.com
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
/PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform to...
Source: prnewswire.com